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Purpose: To assess the diagnostic performance of the focal disturbance 
(FD) ratio calculated by acoustic structure quantification (ASQ) 
technique in assessing the hepatic steatosis and to determine the 
significant affecting factors for FD ratio in a dietary-induced fatty liver 
disease rat animal model using histopathology as a reference of standard.  
Methods: Thirty-two F344 male rats were fed a methionine/choline-
deficient diet with a variable duration (i.e., 0 weeks for the control, a 
half-week, or 1, 2, 3, 4, 5, or 6 weeks; n=4). At the end of each diet period, 
ASQ ultrasound and MR spectroscopy (MRS) were performed. Then, the 
rat was sacrificed and histopathologic examination of the liver was 
performed for the reference of standard. To assess the diagnostic 
performance of the FD ratio in evaluating the degree of hepatic steatosis, 
receiver operating characteristic curve analysis was performed. The 
Spearman correlation coefficient was calculated to assess the correlation 
between the ordinal values, and multivariate linear regression analysis 
was used to identify significant determinant factors for the FD ratio.  
Results: The FD ratio showed excellent diagnostic performance in 
assessing the degree of hepatic steatosis (area under the curve: 1.000 for 
5-33% steatosis, 0.981 for >33-66% steatosis and 0.965 for >66% 




linear correlation between the FD ratio and the estimated fat fraction on 
MRS (Spearman rho, -0.903; P<0.001). The multivariate linear 
regression analysis showed that the degree of hepatic steatosis (P<0.001) 
and fibrosis stage (P=0.022) were significant factors affecting the FD 
ratio.  
Conclusions: The FD ratio could provide good diagnostic performance 
in assessing the degree of hepatic steatosis, with a strong negative linear 
correlation with the estimated fat fraction on MRS. The degree of 
steatosis and stage of fibrosis on histopathology were significant 
affecting factors for FD ratio. 
--------------------------------------------------------------------------------------------- 
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Nonalcoholic fatty liver disease (NAFLD) is a condition of lipid 
accumulation in hepatocytes and is known to be strongly associated with 
the metabolic syndrome characterized by obesity, type 2 diabetes, 
dyslipidemia and atherosclerotic cardiovascular disease (1-4). NAFLD 
represents a broad spectrum of diseases, ranging from simple steatosis to 
nonalcoholic steatohepatitis (NASH), which can further progress into 
fibrosis, cirrhosis and eventually end-stage liver disease requiring liver 
transplantation when not adequately treated (5). In addition, NAFLD is 
currently considered the most common cause of chronic liver disease in 
the Western world, with a prevalence of 30% in the general population 
(6, 7). Therefore, the early detection and assessment of NAFLD using 
quantitative measurement of hepatic steatosis are of crucial importance 
to achieve earlier treatment and prevent progression to cirrhosis. 
Traditionally, liver biopsy is considered the gold standard for the 
diagnosis and quantification of hepatic steatosis (8). However, liver 
biopsy has intrinsic limitations, including potential sampling errors and 
complications such as bleeding (9). Moreover, due to the invasive nature 
of this procedure and its potential complication, repeated liver biopsy is 
often difficult to perform when disease monitoring is required. Therefore, 




and quantification of hepatic steatosis. For this purpose, ultrasound (US), 
computed tomography (CT) and magnetic resonance imaging with 
spectroscopy have been used. Among them, hydrogen 1 (1H) magnetic 
resonance spectroscopy (MRS) has been considered an alternative, non-
invasive standard to assess hepatic steatosis due to its high diagnostic 
accuracy and reproducibility (10, 11). Additionally, recently developed 
T2*-corrected multi-echo MR imaging such as IDEAL has been known 
to be an accurate and reproducible method for assessing the hepatic 
steatosis (12-14). However, MRS and MRI are expensive; therefore, it is 
also not easily repeated to monitor the degree of hepatic steatosis. The 
availability of MR can be another drawback because its availability is 
limited compared with other imaging modalities such as US or CT.  
US can potentially be a good imaging modality that is minimally 
invasive and inexpensive and that can be performed repeatedly without 
risk to the patient. However, US has an intrinsic limitation for the 
quantification of hepatic steatosis, and the subjective nature of the 
examination is a major drawback of US. 
Recently, acoustic structure quantification (ASQ), a commercially 
available quantification method provided by Toshiba medical system 
(Otawara, Japan), has been introduced in clinical practice for the 
evaluation of diffuse liver disease. In the ASQ technique, theoretical 




distribution, and the theoretical echo amplitude distribution of the liver 
region is thought to be a function of the Reyleigh distribution based on 
the assumption that the speckle pattern is induced only by US 
interference of very small scattering objects, which are located closer 
than the US wavelength (15, 16). However, the real echo amplitude 
distribution of the normal liver parenchyma actually does not fit a 
Reyleigh distribution mainly due to the presence of small structures such 
as hepatic vessel walls that scatter the US. As the degree of steatosis 
increases, the real echo amplitude distribution can become more similar 
to the theoretical echo amplitude distribution (i.e., Reyleigh distribution) 
with the blurring of the small structures, including hepatic vessels wall 
(15, 16). According to the results of recent studies, the focal disturbance 
(FD) ratio, calculated by using ASQ technique, was significantly 
correlated with the degree of hepatic steatosis in both an animal model 
(15) and a human study (16).  
However, previous studies did not assess the potential affecting factors, 
such as concurrent inflammation or fibrosis, for the value of the FD ratio 
calculated by ASQ on the evaluation of hepatic steatosis. For the 
widespread clinical application of the ASQ technique as a quantitative 
biomarker for the evaluation of hepatic steatosis, potential affecting 
factors for the FD ratio in the quantification of hepatic steatosis should 




for the assessment of hepatic steatosis must also be evaluated. Therefore, 
the purpose of our study was to assess the diagnostic performance of the 
(FD ratio calculated by ASQ technique in assessing the hepatic steatosis 
and to determine the significant affecting factors for FD ratio in a dietary-
induced fatty liver disease rat animal model using histopathology as a 





MATERIALS AND METHODS 
Animals 
This animal study was approved by our Institutional Animal Care and 
Use Committee IACUC No. 14-0176). Male F344 rats weighing 250-
300 g were acclimatized for 1 week under standardized laboratory 
conditions with a 12-h light/dark cycle in a temperature-controlled room. 
Fatty liver disease was induced by feeding a methionine/choline-
deficient (MCD) diet (Dyets, Bethlehem, PA) ad libitum for a half-week, 
or 1, 2, 3, 4, 5, or 6 weeks (n=4 per group), whereas the control group 
(n=4) was maintained on a standard diet (5, 17, 18). At the end of each 
diet period, US examination using the ASQ technique and 1H-MRS were 
performed to assess the degree of steatosis. Immediately after the 
imaging studies, the rats were sacrificed, and the livers were excised for 
histopathologic examination. 
 
US examination  
All US examinations were carried out using a US scanner (Aplio XG; 
Toshiba Medical Systems, Otawara, Japan) with a 12-MHz linear 
transducer (PLT-1204BT) by author with 9 years of experience in liver 
US imaging. The display depth and transmit focus were set at 30 mm and 




parenchyma were obtained initially. US images in the ASQ mode were 
then acquired five times for each animal, and regions of interest (ROIs) 
as large as possible were placed on the liver parenchyma, with care taken 
to avoid large hepatic vessels or artefacts (Figure 1). The FD ratio values 
were calculated by the system and displayed on the monitor and were 











































Figure 1. US examination using ASQ technique, 1H MRS and 









(a) The setup of micro-coil and rat for MRS examination. 
Anaesthesia is induced by intraperitoneal injection of ketamine and 
rat is set in prone position into the dedicated micro-coil for MRS 
acquisition. (b) Left: Volumetric T1-weighted images of the liver 
were obtained and shown as axial image. Right: 10x10x10-mm3 
sized voxel was applied in central portion of liver parenchyma 
avoiding inclusion of the extrahepatic structures. (c) Top: 
representative spectrum of MRS for echo time (TE) of 12 msec. 
Arrow indicates fat peak and arrow head indicates water peak. 
Bottom: plot of echo time versus signal intensity for water and fat 
extrapolated from top graph to echo time of 0 msec. Arrow indicates 
extrapolated line for fat and arrow head indicates extrapolated line 
for water. a.u.=arbitrary units, S.I=signal intensity. (d) The estimated 
fat fraction in this exam is 12.29%. (e) ASQ examination obtained 
from a rat fed by MCD diet for 1 week. The ROI is placed in liver 
left lobe parenchyma avoiding large hepatic vessels or artefacts and 
the calculated FD ratio in this exam is 0.19. (f), Grade 2 steatosis 








Principles of Acoustic Structure Quantification and Calculation of FD 
Ratio 
Acoustic structure quantification (ASQ) is a newly developed 
quantitative method that analyses the statistical information of the 
acquired echo signals. In ASQ technique, statistical analysis is based on 
the comparison of difference between theoretical and real echo 
amplitude distribution. Theoretical amplitude comes from Rayleigh 
distribution. A dispersion value from a Rayleigh distribution of a signal 
amplitude distribution of reception signals is calculated by performing 
statistical filtering process above, so as to express the calculated 
dispersion value in an image (1-3).  
Theoretical echo amplitude is thought to be a function of the Rayleigh 
distribution based on the assumption that the speckle pattern is induced 
only by US interference of very small scattering objects, which are 
located closer than US wavelength (16). However, real echo amplitude 
of the liver parenchyma actually does not fit a Rayleigh distribution 
mainly due to the presence of small structures such as hepatic vessel 
walls that scatter the US. As hepatic steatosis progresses, liver 
parenchymal echogenicity increases and small structures such as blood 
vessel walls are obscured. Therefore, real echo amplitude of fatty liver 
might be more likely to be a theoretical echo amplitude and fit a Rayleigh 




In ASQ examination, when the examiner sets a comprehensive region 
of interest (ROI) on the image (hereafter, refed as a large ROI), several 
hundred of small ROIs (hereafter, small ROIs) are automatically set 
therein for the calculation of probability density function (PDF) (Figure 
2). The average and variance of the echo amplitude in a small ROI is 
calculated for each small ROI, and essential parameter of Cm
2 (intensity 
or amplitude value) is estimated. Multiple results for small ROIs in a 
large ROI are displayed as an occurrence histogram of C2 (red line in 
Figure 2) (15). Then, to calculate focal disturbance (FD) ratio, Cm
2 (ASQ 




2 (μ) = (π / (4- π)) σm
2 / μ2 
 Where μ and σ2 are the average and variance of the echo amplitude in a 
small ROI, and σm
 is the variance calculated from the limited samples 
less than μ + 4σ. When the ratio C2/Cm
2 is larger than threshold α, the 
result of Cm
2 is eliminated from the histogram (red line in Figure 2), but 
added to the alternative histogram (blue line in Figure 2) (15). As second 
step, the FD ratio can be calculated the ratio of the area under the curve 
(AUC) for these to histogram: FD ratio = [AUC (red) /AUC (blue)] 
(Figure 1). If the threshold α was set to 1.2, FD ratio = 0 when the 
obtained echo amplitude fits a Rayleigh distribution for PDF, and has a 
positive value in case of the presence of tiny structural changes (15). As 




Rayleigh distribution increases, the strength of the signal obtained from 
that ROIs would become more non-homogeneous. When hepatic 
steatosis occurs, hepatic parenchymal echogenicity increases due to the 
deposition of fat droplet and small hepatic vessel walls would become 
blurred. Therefore, echogenicity of fatty liver would be more 
homogeneous, and the number of focally inhomogeneous small-ROIs 
decreases. This can result in the decrease of FD ratio. With this manner, 
FD ratio calculated by ASQ technique can provide quantitative 
information regarding the change of echo-texture during the 


















Figure 2. ASQ quantification using US image obtained from a rat fed by 
MCD diet for 1 week. When examiner set a large ROI (yellow circle) in 
liver left lobe parenchyma avoiding large vessels, several hundred of 
small ROIs (green circles) are automatically set within large ROI for the 









1H-MR Spectroscopy  
 All 1H-MRS measurements were performed on a clinical 3.0T MR 
scanner (Trio Tim System; Siemens Healthcare, Erlangen, Germany) 
with a 5-cm inner diameter experimental dedicated 6 channel rat body 
coil (STARK CONTRAST MRI Coils Research, Erlangen, Germany). 
Scout images were acquired to localize the liver and surrounding 
structures, and volumetric T1-weighted images of the liver were obtained 
using the Radial VIBE sequence to avoid breathing motion artefacts. For 
the fat fraction spectroscopy measurement, the HISTO WIP (Work-in-
Progress, not commercially released yet) sequence (echo times 
msec/repetition time msec, 12, 24, 36, 48 and 72/3000) was employed 
using a 101010-mm3 voxel size located on the liver parenchyma to 
avoid inclusion of the extrahepatic structures. The hepatic fat fraction 
was calculated through T2 correction for both the water and lipid 
contents. Each T2 value of water and fat was calculated separately, and 
extrapolation of fat and water integrals for an echo time of 0 msec by 
using an exponential fit of the points acquired at five different echoes by 
automatic fitting of water (4.7 ppm) and the major fat peak of methylene 
(1.3 ppm) was done for fat quantification (10, 14). The hepatic fat 
fraction was calculated automatically and displayed as a percentage in 
Distal Imaging and Communications in Medicine format. Dedicated coil 




quantification using MRS are given in Figure 1. 1H-MRS examination 
was done five times for each animal, and mean value of hepatic fat 
fraction was calculated for further analysis. 
 
Histopathologic examination  
The excised liver specimens were fixed in 10% buffered formalin for 
24 hours, dehydrated and embedded in paraffin. Next, 5-μm-thick 
sections were stained with haematoxylin and eosin and Masson’s 
trichrome. The sections were evaluated by an experienced pathologist 
with 15 years of experience in liver pathology using the histological 
scoring system for NAFLD (2). In this scoring system, the degree of 
steatosis is classified into four groups: score 0, less than 5% steatosis; 
score 1, 5-33% steatosis; score 2, >33-66% steatosis; and score 3, more 
than 66% steatosis. Lobular inflammation (score 0-3) and hepatocyte 
ballooning (score 0-2) were assessed according to the histological 
scoring system for NAFLD (2). Thereafter, the final NAFLD activity 
score (NAS) which is defined as unweighted sum of the score of steatosis 
(0-3), lobular inflammation (0-3) and hepatocyte ballooning (0-2); thus 
ranging from 0 to 8 was determined (2). The stage of fibrosis (stage 0-4) 






Categorical variables were compared using Fisher’s exact test, and 
continuous variables were evaluated using the Kruskal-Wallis test. The 
hepatic fat fraction assessed on 1H-MRS and FD-ratio calculated using 
the ASQ technique were expressed as means ± standard deviation 
throughout the study. Receiver operating characteristic (ROC) analysis 
was performed to evaluate the diagnostic performance of the FD ratio 
calculated by the ASQ technique for the assessment of the degree of 
steatosis determined on histopathology. The area under the curve (AUC) 
was calculated, and the optimal cut-off value as well as corresponding 
sensitivity, specificity, positive predictive value and negative predictive 
value were also determined. The Spearman correlation coefficient was 
used to assess the correlation between the ordinal variables. To determine 
the factors significantly affecting the FD ratio, multivariate linear 
regression analysis was performed. All of the statistical analyses were 







Induction of fatty liver disease by the MCD diet 
Changes in histopathology, the estimated fat fraction on MRS and the 
calculated FD ratio by the ASQ technique among the rat animal groups 
are summarized in Table 1. Control rat liver showed no steatosis on either 
the histologic examination or the MRS. A half-week MCD diet induced 
grade 1 or 2 steatosis (mean estimated fat fraction on MRS: 6.99 ± 
0.71%), and a one-week MCD diet caused grade 2 or 3 steatosis (mean 
estimated fat fraction on MRS: 18.9 ± 5.6%). After a two-week MCD 
diet, grade 3 steatosis on histopathology and more than 30% of the 
estimated fat fraction on MRS were achieved in most of the animals 
(Figure 1). The degree of lobular inflammation was also significantly 
increased as the duration of MCD diet was prolonged. Accordingly, the 
final NAFLD activity score (NAS) was significantly increased as the 
duration of the MCD diet was prolonged. Fibrosis was first observed 
after a half-week MCD diet, and stage 2 fibrosis was induced after 5 or 
6 weeks of the MCD diet (Figure 3). The FD ratio calculated by the ASQ 
technique was significantly decreased along with the prolonged duration 





Table 1. Changes in histopathology, the estimated fat fraction on 
MRS and the FD ratio calculated by the ASQ technique among the 
animal groups 














0;0;0;1 0;1;1;0 1;1;0;0 0;0;0;0 0;0;0;0 1;0;0;0 1;1;1;1 1;1;1;1 0.013† 
Fibrosis*    
(0-4) 
0;0;0;0 1;1;1;1 1;1;1;1 1;1;0;1 0;1;1;0 1;1;1;1 2;2;2;1 1;1;2;2 <0.001† 
NAS* 0;0;0;1 3;2;3;2 7;5;4;3 5;4;5;4 5;4;4;4 5;6;5;5 7;7;7;7 7;6;7;7 <0.001† 
Fat fraction on 








































Note: *=grade and score of each rat animal in each group. Each group comprised four 
rats; MRS=magnetic resonance spectroscopy; FD ratio=focal disturbance ratio; 
ASQ=acoustic structure quantification; NAS=nonalcoholic fatty liver disease activity 
score which is defined as unweighted sum of the score of steatosis (0-3), lobular 
inflammation (0-3) and hepatocyte ballooning (0-2); thus ranging from 0 to 8. 
 
†: P-values were determined by Fisher’s exact test and other P-values were determined 























Figure 3. Histological changes (x 100) during the MCD diet. (a) 
Control group shows no steatosis on H & E staining. The estimated 
fat fraction on MRS was 1.62% and FD ratio calculated by ASQ 
technique was 0.667. (b) A half-week MCD diet induced score 1 
steatosis (i.e., 5-33% of steatosis) on H & E staining. The estimated 
fat fraction on MRS was 6.38% and FD ratio calculated by ASQ 
technique was 0.316. (c and d) Two-week MCD diet induced score 
(a) (b) 





3 steatosis (i.e., more than 66% of steatosis) on H & E staining (c), 
but no fibrosis on Masson’s trichrome staining (d). The estimated fat 
fraction on MRS was 40.7% and FD ratio calculated by ASQ 
technique was 0.106. (d and e) Six-week MCD diet induced score 3 
steatosis (i.e., more than 66% of steatosis) on H & E staining (d) and 
stage 2 fibrosis on Masson’s trichrome staining (e). The estimated 
fat fraction on MRS was 38.1% and FD ratio calculated by ASQ 












Diagnostic Performance of the FD ratio calculated by ASQ to assess 
the degree of hepatic steatosis 
  The diagnostic performance of the FD ratio and estimated fat fraction 
on MRS for assessing the degree of hepatic steatosis are summarized in 
Table 2. The area under the curve for the diagnosis of grade 1 (5-33% 
steatosis), grade 2 (>33-66% steatosis) and grade 3 steatosis (greater than 
66% steatosis) were 1.000, 0.981 and 0.965, respectively, for the FD ratio 
calculated by the ASQ technique and 1.000, 0.994 and 0.962, 
respectively, for the estimated fat fraction on MRS (Figure 4). There was 
no significant difference between the FD ratio calculated by the ASQ 
technique and estimated fat fraction on MRS for the assessment of the 
degree of hepatic steatosis (P=1.000 for grade 1 steatosis, P=0.286 for 












Table 2. Optimal cut-off values of the FD ratio and estimated fat fraction 












































































































Note: FD ratio=focal disturbance ratio; MRS=magnetic resonance spectroscopy; 
S1=steatosis of 5-33% on histopathology; S2=steatosis of >33-66% on histopathology; 
S3=steatosis > 66% on histopathology; AUC=area under the curve; CI=confidence 











Figure 4. ROC curves of the FD ratio calculated by the ASQ 
technique and estimated fat fraction on MRS for the diagnosis 
of grade 1 steatosis (a), grade 2 steatosis (b) and grade 3 steatosis 
(c). There was no significant difference between the FD ratio and 










P=1.000 P=0.954 P=0.286 





Correlation between the FD ratio calculated by ASQ and estimated fat 
fraction on MRS 
There was a strong negative linear correlation between the FD ratio 
calculated by ASQ technique and the estimated fat fraction on MRS 
(Figure 5). The Spearman rho correlation coefficient was -0.903 (95% 















Figure 5. Scatter plot showing a strong negative linear 
correlation between the FD ratio calculated by the ASQ 
technique and the estimated fat fraction on MRS. 
  





Factors affecting the FD ratio calculated by the ASQ technique 
The FD ratio calculated by the ASQ technique significantly decreased 
as the degree of steatosis, lobular inflammation, and stage of fibrosis 
increased on histopathology (Figure 5). The FD ratio was also 
significantly decreased with the increase in NAS (Figure 5). By contrast, 
the degree of hepatocyte ballooning was not significantly associated with 
the FD ratio. The factors affecting the FD ratio calculated by the ASQ 
technique are summarized in Table 3. The multivariate linear regression 
analysis showed that the degree of hepatic steatosis and stage of fibrosis 
were factors significantly affecting the FD ratio calculated by the ASQ 
technique. Lobular inflammation, hepatocyte ballooning and NAS did 
not significantly affect the value of the FD ratio. The FD ratio calculated 
by the ASQ technique in 20 rats with grade 3 steatosis (i.e., more than 
66% steatosis) was significantly decreased along with the increase in 










Note: FD ratio=focal disturbance ratio; ASQ=acoustic structure quantification; 








Coefficient 95% CI P-value Coefficient 95% CI P-value 
Stage of fibrosis -0.18 -0.26 to -0.10 <0.001 -0.06 -0.07 to -0.03 0.022 
Hepatocyte ballooning -0.07 -0.20 to 0.06 0.266    
Degree of steatosis -0.16 -0.18 to -0.13 <0.001 -0.15 -0.18 to -0.12 <0.001 
Lobular inflammation -0.12 -0.16 to -0.08 <0.001 -0.02 -0.05 to 0.01 0.435 



































Figure 6. Box plots showing the distribution of the FD ratio 
calculated by the ASQ technique according to the degree of 
steatosis (a), degree of lobular inflammation (b), degree of 
hepatocyte ballooning (c), final NAFLD activity score (d), and 
stage of fibrosis (e, 32 rats in total; f, 20 rats with grade 3 
steatosis). Central box represents interquartile range (25 to 75 
percentile) and the middle line represents the median value of 
FD ratio in each animal group. The vertical line extends from 
the minimum to the maximum value, excluding outliers which 















In our study, the diagnostic performance of the FD ratio calculated by 
the ASQ technique for the assessment of the degree of hepatic steatosis 
seemed to be good and might be comparable to that of the estimated fat 
fraction on MRS, using the histopathology as a reference of standard. In 
addition, there was a strong negative linear correlation between the FD 
ratio and the estimated fat fraction on MRS. 
Recently, Kuroda et al. reported that the FD ratio calculated by the 
ASQ technique was significantly correlated with the fat accumulation on 
histopathology in a leptin-deficient mouse model (15). However, in that 
study, the authors did not evaluate the diagnostic performance of the FD 
ratio in predicting the degree of hepatic steatosis on histopathology. In 
addition, the number of examined animal was small (n=9) in the study 
performed by Kuroda et al. Son et al. also reported that the FD ratio 
calculated by the ASQ technique showed a strong negative correlation 
with the estimated fat fraction on MRS in their patient cohort with fatty 
liver disease, and may be used for the detection of hepatic steatosis 
greater than 10% in living donor liver patients (16). However, in their 
study, there was a lack of histopathologic analysis; therefore, they could 
not evaluate the relationship between the FD ratio calculated by the ASQ 
and the changes in histopathology. Our study clearly showed both a 




with the degree of hepatic steatosis and a good diagnostic performance 
of the FD ratio in the assessment of the degree of hepatic steatosis. 
However, as we used a 12-MHz linear transducer for small animal in this 
study, applicability of ASQ technique using a 5-MHz convex human 
abdominal transducer should be evaluated for clinical use of this 
technique. Recently, Son et al reported that ASQ technique using a 5-
MHz convex transducer may be valuable for the evaluation and 
quantification of hepatic steatosis (16), and given that, we would expect 
ASQ using a 5-MHz convex transducer can also be a good method for 
the evaluation of hepatic steatosis in patients group. As FD ratio 
calculated ASQ technique can provide good diagnostic performance in 
assessing the degree of hepatic steatosis, ASQ might be used for the 
evaluation of fatty liver disease patients. In addition, as ASQ technique 
can easily be repeated with no risk to patients and relatively low cost 
compared to MR, FD ratio calculated by ASQ technique can also be used 
for monitoring of fatty liver disease after the initial diagnosis. 
As hepatic steatosis progresses, hepatic parenchymal echogenicity 
increases, and wall of small hepatic vessel or bile duct can be obscured. 
Therefore, pixels with large variance could be decreased, and the 
decreased number of pixels with large variance resulted in the decrease 
in FD ratio calculated by ASQ: this theoretical background of FD ratio 




Traditionally, increased liver parenchymal echogenicity compared 
with renal parenchyma on B-mode US imaging has been regarded to be 
indicative of the presence of hepatic steatosis, and the hepatorenal ratio 
has been subsequently suggested for the quantitative assessment of the 
degree of hepatic steatosis (19-21). However, the assessment of hepatic 
parenchymal echogenicity is subjective in nature, and the quantitative 
evaluation of hepatic steatosis can scarcely be performed with B-mode 
US imaging alone. Furthermore, whether the hepatorenal ratio is 
sufficient for the quantification of hepatic steatosis as an alternative to 
MRS, which has been considered the standard of reference for the non-
invasive diagnosis of hepatic steatosis, remains questionable (16). 
Although one study reported that the hepatorenal ratio showed an 
excellent correlation with the degree of steatosis as assessed by MRS 
(22), other studies have emphasized the need for an additional process 
such as a standardized or artificial neural network to reach the sufficient 
diagnostic performance of the hepatorenal ratio for the assessment of 
hepatic steatosis (21, 23). Controlled attenuation parameter (CAP) 
obtained from transient elastography has been known to be another 
promising tool for the non-invasive evaluation of hepatic steatosis (24, 
25). CAP measures the ultrasound beam attenuation by hepatic fat at the 
central frequency of the transient elastography M probe (26), and could 




background from ASQ used in this study. However, when comparing the 
ASQ from CAP, ASQ evaluation can easily be cooperated with the 
routine B-mode examination as ASQ uses the same transducer used in 
routine B-mode, and this could be a merit of ASQ over CAP.  
In addition to the degree of steatosis, the stage of fibrosis on 
histopathology was also a significant determinant factor of the FD ratio 
calculated by the ASQ technique in our study. As hepatic fibrosis 
develops and progresses, speckles of the liver parenchyma change from 
homogeneous to heterogeneous (27). The presence of fibrosis can also 
change the liver parenchymal echogenicity and cause the blurring of 
small structures such as hepatic vessels and the bile duct, especially in 
initial stage. Therefore, the presence and stage of hepatic fibrosis can 
also affect the value of the FD ratio calculated by the ASQ technique. In 
our study, the FD ratio calculated by the ASQ technique was significantly 
different among the different stages of fibrosis in 20 rats with grade 3 
steatosis on histopathology (i.e., more than 66% steatosis) and clearly 
showed the effect of fibrosis on the value of the FD ratio. Therefore, 
when the FD ratio calculated by the ASQ technique is planned to be used 
as the quantitative biomarker for the degree of hepatic steatosis, the 
possibility of concurrent hepatic fibrosis should be considered because it 
can affect the value of the FD ratio. The combination of shear-wave 




shear-wave elastography can evaluate the degree of hepatic fibrosis and 
presence of cirrhosis accurately (28-31), and thereby can have a potential 
to improve the diagnostic performance of the FD ratio for the assessment 
of hepatic steatosis. However, to evaluate whether the combination of 
elastography can enhance the accuracy of the FD ratio calculated by the 
ASQ technique for the assessment of the degree of hepatic steatosis, 
further study with a larger population size and a prospective design is 
warranted.  
Our study had some limitations. Because the most advanced stage of 
fibrosis in our rat animal model was stage 2, we could not assess the 
effect of more advanced stages of fibrosis or cirrhosis based on the value 
of the FD ratio calculated by the ASQ technique, and this could be a 
limitation of our study. In addition, the number of rats with mild to 
moderate steatosis could be considered relatively small compared with 
those with severe steatosis (8 rats with mild to moderate steatosis vs. 20 
rats with severe steatosis), and this could be a limitation for the statistical 
power. Indeed, small number of animal with mild degree steatosis could 
limit the clinical value of our study, as exact quantitative assessment of 
hepatic steatosis among the patients with mild fatty liver might be 
important in clinical practice, especially for the selection of candidate for 
living liver donor. In addition, as the degree of hepatic steatosis on 




somewhat wide ranges, our results might be optimistic, particularly 
regarding the comparison of diagnostic performance between ASQ 
technique and MRS. Use of special staining such oil-red O staining with 
digital image analysis has been known to be more accurate for 
quantitative assessment of hepatic steatosis on histopathology compared 
to estimation with H & E staining used in our study (32). As we did not 
use this special staining, this could be another limitation. 
In conclusion, the FD ratio calculated by the ASQ technique could 
provide good diagnostic performance for the assessment of the degree of 
hepatic steatosis with a strong negative linear correlation with the 
estimated fat fraction on MRS, and the degree of steatosis and stage of 
fibrosis on histopathology are factors that significantly affect the FD 
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서론: 이 연구에서는 음량구조정량화기법 (Acoustic structure 
quantification, ASQ)을 이용한 초음파 검사에서 구한 국소변이 (focal 
disturbance ratio, FD ratio) 값이 지방 정량화에 사용될 수 있는가와 
FD ratio 에 영향을 주는 인자를 식이 유도 지방간 동물 모델에서 병
리조직 검사 결과를 표준으로 알아보는 것을 목적으로 하였다.  
방법: 250-300 그램의 몸무게를 가진 rat 32 마리를 메티오닌-콜린 결핍 
식이 (Methionine-Choline deficiency diet)을 이용하여 지방간 모델을 유
도하였다. 식이 기간은 0.5, 1, 2, 3, 4, 5, 6 주로 7 그룹으로 나누었으며, 
한 그룹은 대조군으로 정상 식이를 유지하였고 각각의 그룹에는 4 마
리의 rat이 속하도록 하였다. 각각 식이 기간의 마지막 날 ASQ 기법을 
이용한 초음파 검사와 자기공명 분광 기법 검사를 시행하였으며, 영
상 검사 직후 rat 을 안락사 시킨 후 간을 적출하여 병리조직학적 검사
를 시행하였다. ASQ기법을 이용한 초음파 검사에서는 FD ratio를 측정
하여 기록하였으며, 자기공명 분광 기법 검사에서는 추정 지방 분율
을 구하였다. FD ratio 와 추정 지방 분율이 병리조직학적 검사에서 평
가한 각각 지방간의 등급을 예측하는 진단능을 평가하기 위해 ROC 
분석을 시행하였다. ASQ 기법을 이용한 초음파 검사에서 얻은 FD 
ratio와 자기 공명 분광 기법 검사에서 얻은 추정 지방 분율 사이의 상




ratio 에 영향을 미치는 병리조직학적 요인을 찾기 위해 multivariate 
linear regression 분석을 시행하였다.  
결과: ASQ 기법을 이용한 초음파 검사에서 얻은 FD ratio 는 병리조직
검사에서 결정된 지방간 등급의 예측에 있어서 훌륭한 진단능을 
보여주었다 (area under the curve: 1.000 for 5-33% steatosis, 0.981 for 
>33-66% steatosis and 0.965 for >66% steatosis). FD ratio 와 자기 공명 
분광 기법 검사에서 얻은 추정 지방 분율 사이에는 강한 음의 선
형 상관 관계가 있었다 (Spearman 상관계수, -0.903; P<0.001). 병리
조직학적 요인 중 지방간의 정도와 섬유화의 정도가 FD ratio 에 
유의한 영향을 주는 요인이었다.  
결론: ASQ 기법을 이용한 초음파 검사에서 얻은 FD ratio 는 지방간의 
정량적 평가에 있어서 좋은 진단능을 가지고 있으며, 자기 공명 분
광 기법 검사에서 얻은 추정 지방 분율과 강한 음의 상관관계를 가
지고 있다. 병리 검사에서 평가된 지방간의 정도와 섬유화의 정도가 
FD ratio를 결정하는 주요 요인이었다.  
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